PDCD1 and hepatocellular carcinoma: Given the multiple Wnt pathway inhibitors currently under development, this study aims to explore the impact of Wnt pathway inhibition on PD-L1 expression in HCC cells and the potential of combining Wnt pathway inhibitors with PD-1 blockade as a treatment strategy for HCC.